| Price | 2.07 |
| Price Change Today | -$0.27 (-11.54%) |
| P&P rating | ![]() |
| Zacks Rank | N/A - N/A |
| Open Price | $2.34 |
| Previous Close | $2.34 |
| Daily Range | $2.00 - $2.34 |
| 52-Week Range | $2.00 - $8.25 |
| Volume | 66,034 |
| NOVOGEN LTD-ADR business is in the area of medicine know as degenerative diseases and disorders. Novogen is addressing this urgent area of medical need through the Novogen isoflavonoid technology platform - a platform that the Company believes offers the real prospect of not only treating, but also preventing, the onset of these common degenerative conditions. There are three divisions at Novagen: the pharmaceutical division, Marshall Edwards inc., and the consumer health division. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment